VYNE Therapeutics Inc. (YARW)

Last Closing Price: 35.02 (2026-07-31)

Earnings Announcements: Estimated vs Actual

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.

Announcement Date Fiscal Quarter End Estimated EPS Actual EPS
2026-05-15 2026-03-31 -- $-4.00
2025-11-06 2025-09-30 $-9.50 $-8.50
2025-08-14 2025-06-30 $-11.50 $-6.50
2025-05-08 2025-03-31 $-14.50 $-10.00
2025-03-06 2024-12-31 $-15.50 $-14.00
2024-11-07 2024-09-30 $-12.00 $-14.50
2024-08-14 2024-06-30 $-9.50 $-11.00
2024-05-09 2024-03-31 $-12.00 $-7.50
2024-02-29 2023-12-31 $-25.00 $-10.00
2023-11-13 2023-09-30 $-38.00 $-92.50
2023-08-14 2023-06-30 $-99.50 $-154.00
2023-05-11 2023-03-31 $-125.00 $-87.00
2023-03-09 2022-12-31 $-162.00 $-130.00
2022-11-10 2022-09-30 $-143.88 $-143.88
2022-08-12 2022-06-30 $-161.87 $-125.90
2022-05-12 2022-03-31 $-143.88 $-143.88
2022-03-17 2021-12-31 $-197.84 $-197.84
2021-11-10 2021-09-30 $-296.76 $-368.71
2021-08-12 2021-06-30 $-323.74 $-350.72
2021-05-06 2021-03-31 $-431.65 $-377.70
2021-03-04 2020-12-31 $-485.61 $-494.60
2020-11-05 2020-09-30 $-683.45 $-539.57
2020-08-06 2020-06-30 $-755.40 $-4352.52
2020-05-11 2020-03-31 $-1798.56 $-3417.27
2020-03-03 2019-12-31 $-2985.61 $-3201.44
2019-10-31 2019-09-30 $-2733.81 $-2517.99
2019-08-01 2019-06-30 $-3021.58 $-2482.01
2019-05-02 2019-03-31 $-2913.67 $-2913.67
2019-02-27 2018-12-31 $-2841.73 $-2733.81
2018-11-07 2018-09-30 $-3021.58 $-2014.39
2018-08-01 2018-06-30 $-2877.70 $-1294.96
2018-05-09 2018-03-31 $-2446.04 $-2589.93
2018-03-28 2017-12-31 -- $-6474.82